Literature DB >> 23645221

Intracerebral hemorrhage during anticoagulation with vitamin K antagonists: a consecutive observational study.

S Horstmann1, T Rizos, M Lauseker, M Möhlenbruch, E Jenetzky, W Hacke, Th Steiner, R Veltkamp.   

Abstract

Intracerebral hemorrhage (ICH) is the most devastating complication of oral anticoagulation (OAC). As the number of patients on long-term OAC is expected to rise, the proportion of intracerebral hemorrhage related to OAC (OAC-ICH) in relation to spontaneous ICH (spont-ICH) is expected to increase as well. We determined the proportion of OAC-ICH in consecutive stroke patients and explored differences between OAC-ICH and spont-ICH regarding initial volume, hematoma expansion and outcome. Our prospective study consecutively enrolled patients with supra- and infratentorial ICH. The National Institute of Health Stroke Scale Score and the modified Rankin Scale (mRS) score at baseline and after 3 months, medical history and demographic variables were recorded. All admission and follow-up CTs/MRIs were analysed regarding ICH volume using the ABC/2-method. Intraventricular hemorrhage (IVH) was quantified using the Graeb score. Within 19 months, 2,282 patients were admitted to our ER. 206 ICH patients were included. Overall, 24.8 % of all ICH were related to OAC. Compared to patients with spont-ICH, OAC-ICH patients were older (p = 0.001), more frequently had initial extension of ICH into the ventricles (p = 0.05) or isolated primary IVH (p = 0.03) and a higher Graeb score upon admission (p = 0.01). In contrast, initial ICH volume (p = 0.16) and ICH expansion (p = 0.9) in those receiving follow-up imaging (n = 152) did not differ between the two groups. After correction for age, there was a trend towards poorer outcome in OAC-ICH (p = 0.08). One-fourth of all ICH are related to OAC. Initial extension of ICH into the ventricles and primary IVH are more frequent in OAC-ICH. The rate of hematoma expansion in OAC-ICH patients is similar to non-anticoagulated ICH patients.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23645221     DOI: 10.1007/s00415-013-6939-6

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  29 in total

1.  Fast point-of-care coagulometer guided reversal of oral anticoagulation at the bedside hastens management of acute subdural hemorrhage.

Authors:  Timolaos Rizos; Ekkehart Jenetzky; Christian Herweh; Andreas Unterberg; Werner Hacke; Roland Veltkamp
Journal:  Neurocrit Care       Date:  2010-12       Impact factor: 3.210

Review 2.  Options to restrict hematoma expansion after spontaneous intracerebral hemorrhage.

Authors:  Thorsten Steiner; Julian Bösel
Journal:  Stroke       Date:  2009-12-31       Impact factor: 7.914

3.  Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence.

Authors:  Yoko Miyasaka; Marion E Barnes; Bernard J Gersh; Stephen S Cha; Kent R Bailey; Walter P Abhayaratna; James B Seward; Teresa S M Tsang
Journal:  Circulation       Date:  2006-07-03       Impact factor: 29.690

4.  Patients with nonvalvular atrial fibrillation at low risk of stroke during treatment with aspirin: Stroke Prevention in Atrial Fibrillation III Study. The SPAF III Writing Committee for the Stroke Prevention in Atrial Fibrillation Investigators.

Authors: 
Journal:  JAMA       Date:  1998 Apr 22-29       Impact factor: 56.272

5.  Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.

Authors:  Lewis B Morgenstern; J Claude Hemphill; Craig Anderson; Kyra Becker; Joseph P Broderick; E Sander Connolly; Steven M Greenberg; James N Huang; R Loch MacDonald; Steven R Messé; Pamela H Mitchell; Magdy Selim; Rafael J Tamargo
Journal:  Stroke       Date:  2010-07-22       Impact factor: 7.914

6.  Recommendations for the management of intracranial haemorrhage - part I: spontaneous intracerebral haemorrhage. The European Stroke Initiative Writing Committee and the Writing Committee for the EUSI Executive Committee.

Authors:  Thorsten Steiner; Markku Kaste; Markku Katse; Michael Forsting; David Mendelow; Hubert Kwiecinski; Istvan Szikora; Seppo Juvela; Andrzej Marchel; René Chapot; Christophe Cognard; Andreas Unterberg; Werner Hacke
Journal:  Cerebrovasc Dis       Date:  2006-07-28       Impact factor: 2.762

7.  Determinants of intracerebral hemorrhage growth: an exploratory analysis.

Authors:  Joseph P Broderick; Michael N Diringer; Michael D Hill; Nikolai C Brun; Stephan A Mayer; Thorsten Steiner; Brett E Skolnick; Stephen M Davis
Journal:  Stroke       Date:  2007-02-08       Impact factor: 7.914

8.  Paroxysmal atrial fibrillation is more prevalent than persistent atrial fibrillation in acute stroke and transient ischemic attack patients.

Authors:  T Rizos; A Wagner; E Jenetzky; P A Ringleb; R Becker; W Hacke; R Veltkamp
Journal:  Cerebrovasc Dis       Date:  2011-08-31       Impact factor: 2.762

9.  Predictors of outcome in warfarin-related intracerebral hemorrhage.

Authors:  Alexander Y Zubkov; Jayawant N Mandrekar; Daniel O Claassen; Edward M Manno; Eelco F M Wijdicks; Alejandro A Rabinstein
Journal:  Arch Neurol       Date:  2008-10

Review 10.  Oral anticoagulants and intracranial hemorrhage. Facts and hypotheses.

Authors:  R G Hart; B S Boop; D C Anderson
Journal:  Stroke       Date:  1995-08       Impact factor: 7.914

View more
  8 in total

1.  [Consensus statement: Stroke prevention in nonvalvular atrial fibrillation in special consideration of the new direct oral anticoagulants].

Authors:  Ingrid Pabinger; Wilfried Lang; Franz Xaver Roithinger; Franz Weidinger; Sabine Eichinger-Hasenauer; Reinhold Glehr; Walter-Michael Halbmayer; Hans-Peter Haring; Bernd Jilma; Hans Christian Korninger; Sibylle Kozek-Langenecker; Paul Kyrle; Herbert Watzke; Ansgar Weltermann; Johann Willeit; Kurt Huber
Journal:  Wien Klin Wochenschr       Date:  2014-10-03       Impact factor: 1.704

2.  Coagulation Testing in Intracerebral Hemorrhage Related to Non-vitamin K Antagonist Oral Anticoagulants.

Authors:  Jan C Purrucker; Timolaos Rizos; Kirsten Haas; Marcel Wolf; Shujah Khan; Peter U Heuschmann; Roland Veltkamp
Journal:  Neurocrit Care       Date:  2017-10       Impact factor: 3.210

3.  Modeling the Clinical Implications of Andexanet Alfa in Factor Xa Inhibitor-Associated Intracerebral Hemorrhage.

Authors:  Carlin C Chuck; Daniel Kim; Roshini Kalagara; Nathaniel Rex; Tracy E Madsen; Leana Mahmoud; Bradford B Thompson; Richard N Jones; Karen L Furie; Michael E Reznik
Journal:  Neurology       Date:  2021-09-23       Impact factor: 11.800

Review 4.  Hemorrhagic lesions associated with anticoagulant therapy: a pictorial review.

Authors:  Bahar Yılmaz Çankaya; Fatih Alper; Adem Karaman; Metin Akgün
Journal:  J Thromb Thrombolysis       Date:  2020-10-09       Impact factor: 2.300

5.  Reversal strategies for vitamin K antagonists in acute intracerebral hemorrhage.

Authors:  Adrian R Parry-Jones; Mario Di Napoli; Joshua N Goldstein; Floris H B M Schreuder; Sami Tetri; Turgut Tatlisumak; Bernard Yan; Koen M van Nieuwenhuizen; Nelly Dequatre-Ponchelle; Matthew Lee-Archer; Solveig Horstmann; Duncan Wilson; Fulvio Pomero; Luca Masotti; Christine Lerpiniere; Daniel Agustin Godoy; Abigail S Cohen; Rik Houben; Rustam Al-Shahi Salman; Paolo Pennati; Luigi Fenoglio; David Werring; Roland Veltkamp; Edith Wood; Helen M Dewey; Charlotte Cordonnier; Catharina J M Klijn; Fabrizio Meligeni; Stephen M Davis; Juha Huhtakangas; Julie Staals; Jonathan Rosand; Atte Meretoja
Journal:  Ann Neurol       Date:  2015-05-14       Impact factor: 10.422

Review 6.  Management of Spontaneous Intracerebral Hemorrhage.

Authors:  Roland Veltkamp; Jan Purrucker
Journal:  Curr Neurol Neurosci Rep       Date:  2017-09-08       Impact factor: 5.081

7.  Functional outcome and survival following spontaneous intracerebral hemorrhage: A retrospective population-based study.

Authors:  Lise R Øie; Mattis A Madsbu; Ole Solheim; Asgeir S Jakola; Charalampis Giannadakis; Anders Vorhaug; Llewellyn Padayachy; Heidi Jensberg; David Dodick; Øyvind Salvesen; Sasha Gulati
Journal:  Brain Behav       Date:  2018-09-21       Impact factor: 2.708

8.  Meta-analysis of haematoma volume, haematoma expansion and mortality in intracerebral haemorrhage associated with oral anticoagulant use.

Authors:  David J Seiffge; Martina B Goeldlin; Turgut Tatlisumak; Philippe Lyrer; Urs Fischer; Stefan T Engelter; David J Werring
Journal:  J Neurol       Date:  2019-09-20       Impact factor: 4.849

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.